Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 173

1.

Intrabronkiella ventiler ger god effekt – hos rätt patient.

Hillerdal G.

Lakartidningen. 2019 May 28;116. pii: FMHH. Swedish. No abstract available.

PMID:
31192399
Free Article
2.

Achieving Thoracic Oncology data collection in Europe: a precursor study in 35 Countries.

Rich A, Baldwin D, Alfageme I, Beckett P, Berghmans T, Brincat S, Burghuber O, Corlateanu A, Cufer T, Damhuis R, Danila E, Domagala-Kulawik J, Elia S, Gaga M, Goksel T, Grigoriu B, Hillerdal G, Huber RM, Jakobsen E, Jonsson S, Jovanovic D, Kavcova E, Konsoulova A, Laisaar T, Makitaro R, Mehic B, Milroy R, Moldvay J, Morgan R, Nanushi M, Paesmans M, Putora PM, Samarzija M, Scherpereel A, Schlesser M, Sculier JP, Skrickova J, Sotto-Mayor R, Strand TE, Van Schil P, Blum TG.

BMC Cancer. 2018 Nov 20;18(1):1144. doi: 10.1186/s12885-018-5009-y.

3.

[Black smoke lung disease – a new disease in Sweden].

Palm A, Wilander E, Wallgren S, Hillerdal G.

Lakartidningen. 2017 Dec 18;114. pii: ESC4. Swedish.

4.

Ex vivo evaluation of tumor cell specific drug responses in malignant pleural effusions.

Hillerdal CO, Ötvös R, Szatmári T, Own SA, Hillerdal G, Dackland ÅL, Dobra K, Hjerpe A.

Oncotarget. 2017 Sep 15;8(47):82885-82896. doi: 10.18632/oncotarget.20889. eCollection 2017 Oct 10.

5.

A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (TRANSFORM).

Kemp SV, Slebos DJ, Kirk A, Kornaszewska M, Carron K, Ek L, Broman G, Hillerdal G, Mal H, Pison C, Briault A, Downer N, Darwiche K, Rao J, Hübner RH, Ruwwe-Glosenkamp C, Trosini-Desert V, Eberhardt R, Herth FJ, Derom E, Malfait T, Shah PL, Garner JL, Ten Hacken NH, Fallouh H, Leroy S, Marquette CH; TRANSFORM Study Team *.

Am J Respir Crit Care Med. 2017 Dec 15;196(12):1535-1543. doi: 10.1164/rccm.201707-1327OC.

PMID:
28885054
6.

Occupation and mesothelioma in Sweden: updated incidence in men and women in the 27 years after the asbestos ban.

Plato N, Martinsen JI, Sparén P, Hillerdal G, Weiderpass E.

Epidemiol Health. 2016 Sep 20;38:e2016039. eCollection 2016.

7.

Non-small Cell Lung Cancer (NSCLC) in Octogenarians in Clinical Practice.

Koyi H, Hillerdal G, Kölbeck KG, Brodin D, Liv P, Brandén E.

Anticancer Res. 2016 Oct;36(10):5397-5402.

PMID:
27798905
8.

Lung cancer among native and foreign-born Swedes: histopathology, treatment, and survival.

Koyi H, Hillerdal G, Andersson O, Högberg H, Brandén E.

Acta Oncol. 2016 Nov;55(11):1344-1348. Epub 2016 Aug 24.

PMID:
27556916
9.

[There is evidence for valve treatment in patients with severe emphysema].

Hillerdal G.

Lakartidningen. 2016 Feb 15;113. pii: DWE9. Swedish. No abstract available.

10.

Bilateral endoscopic volume reduction in a woman with severe emphysema.

Hillerdal G.

Clin Respir J. 2017 Nov;11(6):1091-1094. doi: 10.1111/crj.12441. Epub 2017 Jan 17.

PMID:
26703777
11.

When small is better: volume reduction in severe emphysema.

Folch E, Hillerdal G.

Eur Respir J. 2015 Sep;46(3):593-5. doi: 10.1183/09031936.00065715. No abstract available.

12.

Chemotherapy Treatment of Elderly Patients (≥70 Years) with Non-Small Cell Lung Cancer: A Seven-Year Retrospective Study of Real-Life Clinical Practice at Karolinska University Hospital, Sweden.

Koyi H, Hillerdal G, Andersson O, Kölbeck KG, Liv P, Brandén E.

Lung Cancer Int. 2015;2015:317868. doi: 10.1155/2015/317868. Epub 2015 Jul 14.

13.

Feasibility of home delivery of pemetrexed in patients with advanced non-squamous non-small cell lung cancer.

Lal R, Hillerdal GN, Shah RN, Crosse B, Thompson J, Nicolson M, Vikström A, Potter VA, Visseren-Grul C, Lorenzo M, D'yachkova Y, Bourayou N, Summers YJ.

Lung Cancer. 2015 Aug;89(2):154-60. doi: 10.1016/j.lungcan.2015.05.003. Epub 2015 May 12.

PMID:
26101013
14.

Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial.

Krug LM, Kindler HL, Calvert H, Manegold C, Tsao AS, Fennell D, Öhman R, Plummer R, Eberhardt WE, Fukuoka K, Gaafar RM, Lafitte JJ, Hillerdal G, Chu Q, Buikhuisen WA, Lubiniecki GM, Sun X, Smith M, Baas P.

Lancet Oncol. 2015 Apr;16(4):447-56. doi: 10.1016/S1470-2045(15)70056-2. Epub 2015 Mar 20. Erratum in: Lancet Oncol. 2015 May;16(5):e199.

PMID:
25800891
15.

Pemetrexed and gemcitabine versus carboplatin and gemcitabine in non-small cell lung cancer: a randomized noninferiority phase II study in one center.

Branden E, Hillerdal G, Kolbeck K, Koyi H.

Oncologist. 2015 Apr;20(4):365. doi: 10.1634/theoncologist.2014-0181. Epub 2015 Mar 2.

16.

[Screening for lung cancer in Sweden requires large resources].

Koyi H, Hillerdal G.

Lakartidningen. 2015 Feb 3;112. pii: DCCP. Swedish. No abstract available.

17.

One- to four-year follow-up of endobronchial lung volume reduction in alpha-1-antitrypsin deficiency patients: a case series.

Hillerdal G, Mindus S.

Respiration. 2014;88(4):320-8. doi: 10.1159/000365662. Epub 2014 Sep 11.

18.

Home administration of maintenance pemetrexed for patients with advanced non-squamous non-small cell lung cancer: rationale, practicalities and phase II feasibility study design.

Lal R, Bourayou N, Hillerdal G, Nicolson M, Vikstrom A, Lorenzo M, D'yachkova Y, Barriga S, Visseren-Grul C.

Health Qual Life Outcomes. 2013 Oct 3;11:163. doi: 10.1186/1477-7525-11-163.

19.

[Fast track assessment of lung cancer cut the investigation time in half].

Kölbeck KG, Kamareji S, Jacobsson H, Hillerdal G.

Lakartidningen. 2013 Aug 21-Sep 3;110(34-35):1474-6. Swedish. No abstract available.

PMID:
24044184
20.

Hyaluronan and N-ERC/mesothelin as key biomarkers in a specific two-step model to predict pleural malignant mesothelioma.

Mundt F, Nilsonne G, Arslan S, Csürös K, Hillerdal G, Yildirim H, Metintas M, Dobra K, Hjerpe A.

PLoS One. 2013 Aug 21;8(8):e72030. doi: 10.1371/journal.pone.0072030. eCollection 2013.

21.

[Pulmonary tularemia: rare disease that can be interpreted as lung cancer. Serology provides the correct diagnosis, as shown by case reports].

Hillerdal G, Kölbeck K, Jacobsson H.

Lakartidningen. 2013 Apr 3-16;110(27-28):1280-1. Swedish. No abstract available.

PMID:
23951881
22.

Mesothelin and osteopontin.

Hillerdal G.

Eur Respir J. 2013 Aug;42(2):557. doi: 10.1183/09031936.00052213. No abstract available.

23.

Slow-growing lung cancer as an emerging entity: from screening to clinical management.

Infante M, Berghmans T, Heuvelmans MA, Hillerdal G, Oudkerk M.

Eur Respir J. 2013 Dec;42(6):1706-22. doi: 10.1183/09031936.00186212. Epub 2013 May 16. Review.

24.

[Bronchopleural fistula treated with endobronchial vent placement. Successful treatment of feared lung complication].

Riise GC, Hillerdal G, Ek L.

Lakartidningen. 2013 Jan 23-29;110(4):154-6. Swedish. No abstract available.

PMID:
23427724
25.

[Screening for lung cancer can save lives, according to US study. Too early for mass screening--but refer smokers to CT on broad indications].

Koyi H, Hillerdal G.

Lakartidningen. 2012 Feb 1-7;109(5):208-9. Swedish. No abstract available.

PMID:
22458128
26.

LUCADA: a valuable resource but there are questions it cannot answer.

Treasure T, Hillerdal G, Utley M.

Thorax. 2011 Dec;66(12):1023-4. doi: 10.1136/thoraxjnl-2011-200922. Epub 2011 Sep 13. No abstract available.

PMID:
21917651
27.

[Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma].

Scherpereel A, Astoul P, Baas P, Berghmans T, Clayson H, de Vuyst P, Dienemann H, Galateau-Salle F, Hennequin C, Hillerdal G, Le Pe'choux C, Mutti L, Pairon JC, Stahel R, van Houtte P, van Meerbeeck J, Waller D, Weder W; European Respiratory Society; European Society of Thoracic Surgeons.

Zhongguo Fei Ai Za Zhi. 2010 Oct;13(10):C23-45. doi: 10.3779/j.issn.1009-3419.2010.10.14. Chinese. No abstract available.

28.

[Antibiotic-resistant bacteria and feminized fishes. Physicians as environmental marauders].

Hillerdal G.

Lakartidningen. 2010 Sep 29-Oct 5;107(39):2301. Swedish. No abstract available.

PMID:
20973244
29.

Randomized phase II study of gemcitabine and carboplatin +/- sequential docetaxel in non-small cell lung cancer.

Hillerdal G, Sederholm C, Andersson K.

Lung Cancer. 2011 Feb;71(2):178-81. doi: 10.1016/j.lungcan.2010.05.007. Epub 2010 May 23.

PMID:
20546968
30.

Endemic malignant mesothelioma: exposure to erionite is more important than genetic factors.

Metintas M, Hillerdal G, Metintas S, Dumortier P.

Arch Environ Occup Health. 2010 Apr-Jun;65(2):86-93. doi: 10.1080/19338240903390305.

PMID:
20439227
31.

Tuberculosis in the Ottoman harem in the 19th century.

Baris YI, Hillerdal G.

J Med Biogr. 2009 Aug;17(3):170-3. doi: 10.1258/jmb.2009.009012.

PMID:
19723971
32.

Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma.

Scherpereel A, Astoul P, Baas P, Berghmans T, Clayson H, de Vuyst P, Dienemann H, Galateau-Salle F, Hennequin C, Hillerdal G, Le Péchoux C, Mutti L, Pairon JC, Stahel R, van Houtte P, van Meerbeeck J, Waller D, Weder W; European Respiratory Society/European Society of Thoracic Surgeons Task Force.

Eur Respir J. 2010 Mar;35(3):479-95. doi: 10.1183/09031936.00063109. Epub 2009 Aug 28.

33.

Multicentre phase II trial of paclitaxel and carboplatin with concurrent radiotherapy in locally advanced non-small cell lung cancer.

Tell R, Sederholm C, Klintenberg C, Franksson L, Brandén E, Hillerdal G, Lönn U, Lindén CJ, Ewers SB, Lamberg K, Mrazek E, Lödén B, Sjögren A, Linné T, Friesland S, Sirzén F.

Anticancer Res. 2008 Sep-Oct;28(5B):2851-7.

34.

Treatment of malignant pleural mesothelioma with carboplatin, liposomized doxorubicin, and gemcitabine: a phase II study.

Hillerdal G, Sorensen JB, Sundström S, Riska H, Vikström A, Hjerpe A.

J Thorac Oncol. 2008 Nov;3(11):1325-31. doi: 10.1097/JTO.0b013e31818b174d.

35.

Screening for mesothelioma: more harm than good?

van Meerbeeck JP, Hillerdal G.

Am J Respir Crit Care Med. 2008 Oct 15;178(8):781-2. doi: 10.1164/rccm.200806-955ED. No abstract available.

PMID:
18832552
36.

Treatment of malignant pleural mesothelioma with liposomized doxorubicine: prolonged time to progression and good survival. A Nordic study.

Hillerdal G, Sorensen JB, Sundström S, Vikström A, Hjerpe A.

Clin Respir J. 2008 Apr;2(2):80-5. doi: 10.1111/j.1752-699X.2008.00050.x.

PMID:
20298311
37.

Indolent lung cancers--time for a paradigm shift: a review.

Hillerdal G.

J Thorac Oncol. 2008 Mar;3(3):208-11. doi: 10.1097/JTO.0b013e3181653ce3. Review.

38.

Detection of Chlamydia pneumoniae on cytospin preparations from bronchoalveolar lavage in COPD patients and in lung tissue from advanced emphysema.

Brandén E, Gnarpe J, Hillerdal G, Orre L, Sköld CM, Löfdahl M, Koyi H, Tornling G.

Int J Chron Obstruct Pulmon Dis. 2007;2(4):643-50.

39.

Yellow nail syndrome: treatment with octreotide.

Hillerdal G.

Clin Respir J. 2007 Dec;1(2):120-1. doi: 10.1111/j.1752-699X.2007.00022.x.

PMID:
20298292
40.

Malignant mediastinal tumor with bone formation--mesothelioma or sarcoma?

Hillerdal G, Elmberger G.

J Thorac Oncol. 2007 Oct;2(10):983-4.

41.

Eighth international mesothelioma interest group.

Carbone M, Albelda SM, Broaddus VC, Flores RM, Hillerdal G, Jaurand MC, Kjaerheim K, Pass HI, Robinson B, Tsao A.

Oncogene. 2007 Oct 25;26(49):6959-67. Epub 2007 May 14.

PMID:
17496929
42.

[Emphysema surgery--considerably improved quality of life for a specially selected group of patients. Strict selection criteria are very important].

Hillerdal G, Ström K.

Lakartidningen. 2006 Nov 1-7;103(44):3375-6. Review. Swedish. No abstract available.

PMID:
17152259
43.

Pleuropulmonary lesions, ergotamines and asbestos exposure.

Hillerdal G, Rask-Andersen A.

Scand J Work Environ Health. 2005 Dec;31(6):459-64.

44.

Comparison of lung volume reduction surgery and physical training on health status and physiologic outcomes: a randomized controlled clinical trial.

Hillerdal G, Löfdahl CG, Ström K, Skoogh BE, Jorfeldt L, Nilsson F, Forslund-Stiby D, Ranstam J, Gyllstedt E.

Chest. 2005 Nov;128(5):3489-99.

PMID:
16304304
45.
46.

Nonmalignant pleural lesions due to environmental exposure to asbestos: a field-based, cross-sectional study.

Metintas M, Metintas S, Hillerdal G, Ucgun I, Erginel S, Alatas F, Yildirim H.

Eur Respir J. 2005 Nov;26(5):875-80.

47.
48.

Imaging, staging and response evaluation.

Byrne M, Hillerdal G.

Lung Cancer. 2005 Jul;49 Suppl 1:S25-6. Epub 2005 Apr 7. No abstract available.

PMID:
15950795
49.

Inflammatory parameters after pleurodesis in recurrent malignant pleural effusions and their predictive value.

Ukale V, Agrenius V, Widström O, Hassan A, Hillerdal G.

Respir Med. 2004 Dec;98(12):1166-72.

50.

The Swedish experience with asbestos: history of use, diseases, legislation, and compensation.

Hillerdal G.

Int J Occup Environ Health. 2004 Apr-Jun;10(2):154-8. Review.

PMID:
15281373

Supplemental Content

Loading ...
Support Center